China Proposes to Tighten Biosecurity Law and its Potential Impact on Foreign Pharmaceutical and Biotech Companies Operating in China

Published date13 July 2020
Subject MatterLife Sciences,China,Pharmaceutical Industry,Biotechnology,National Security,Legislative Agendas
AuthorYufeng Ma,Betty Louie,Fan (Martha) Wang
Law FirmOrrick, Herrington & Sutcliffe LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT